JLJinghua Liu

Jinghua Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinghua Liu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Efficacy of Antimicrobial Lock Solutions on Central Line‐Associated Bloodstream Infection and Catheter Survival in Hemodialysis Patients: A Systematic Review and Meta‐Analysis

    by Jinghua Liu, Jianpeng Lin, Haihong Liu, KimGeok Soh, Qingmei Ju, KimLam Soh, Xianling Dong

    Hemodialysis (HD) catheters carry a high risk of life‐threatening bloodstream infections and failure. Antimicrobial lock solutions (ALS) are used to reduce this risk, but their overall efficacy on key outcomes like infection rates and catheter survival requires comprehensive evaluation. This systematic review and meta‐analysis assess the impact of ALS on preventing catheter‐related bloodstream infections (including incidence and density) and on improving catheter survival. A systematic search was conducted across the databases of PubMed, Embase, Scopus, Cochrane Library, and Google Scholar. A meta‐analysis was conducted using STATA software. A total of 1183 studies were screened based on title and abstract, and further 282 studies were evaluated in full text. Eventually, 14 studies with 15 treatment arms were included. Key outcomes including central line‐associated bloodstream infection (CLABSI), exit infection, and catheter‐free survival were conducted separately. ALS demonstrated statistically significant benefits on CLABSI infection and catheter‐free survival compared to nonantimicrobial solutions, showing a reduction in CLABSI density with a pooled log odd ratio (logOR) of −1.29 (95% CI: −1.59 to −0.99), lower CLABSI rates (pooled logOR = −1.50, 95% CI: −1.85 to −1.15), and improved catheter‐free survival with log hazard ratio (logHR) of −1.11 (95% CI: −1.41 to −0.8). Consistent treatment effects were observed across all lock types with no significant heterogeneity detected. ALS demonstrate statistically significant and clinically important efficacy in reducing CLABSI incidence and density while improving catheter survival in HD patients, establishing them as an essential preventive strategy in clinical practice.

  • Efficacy of catheter lock solutions on central-line associated bloodstream infections (CLABSI) prevention: A systematic review and Bayesian network meta-analysis

    by Jinghua Liu, Jianpeng Lin, Haihong Liu, Kim Geok Soh, Kim Lam Soh, Xianling Dong

    Catheter lock solutions (CLs) are commonly used to reduce the risk of central line-associated bloodstream infections (CLABSI), but it remains uncertain which type is most beneficial for patients. This systematic review and Bayesian network meta-analysis synthesized available evidence by comparing different CLs directly and indirectly to prevent CLABSI and rank their effectiveness. A comprehensive search was performed across PubMed, Embase, Ovid, Scopus, Cochrane Library, and Google Scholar. After screening 2359 records by title and abstract and reviewing 374 full-text articles, 39 studies were included, covering seven CLs types. Bayesian network meta-analysis was conducted using STATA and ADDIS. Results showed that taurolidine-based (TCLs), ethanol-based (ECLs), gentamicin-based (GCLs), and EDTA-based (EDTA-CLs) solutions were more effective than saline or heparin in preventing CLABSI. According to the surface under the cumulative ranking curve (SUCRA), TCLs had the highest probability of reducing CLABSI (89.1%), followed by GCLs (82.6%) and EDTA-CLs (72.6%). In conclusion, this review underscores the clinical value of catheter lock solutions in CLABSI prevention, with strong evidence supporting the integration of TCLs into central venous catheter maintenance bundles due to their significant benefits.